| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.07 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.3 | 0.07 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.06 | 0.08 |